On August 24, 2026, Hims & Hers Health Inc (NYSE: HIMS) saw its shares fall more than 8% to close at $31.08 following reports that Visa intends to impose penalties approaching $75,000 due to numerous credit card dispute complaints tied to weight-loss subscriptions. This decline came after a strong rally of over 20% in the previous five trading sessions.
- HIMS trades at a Price-to-Sales (P/S) ratio of 2.92, below its historical median of 3.26 but above the industry median, reflecting market expectations for continued rapid growth despite ongoing losses; earnings-based valuation metrics like P/E are not applicable given the company’s unprofitable status.
- Insider activity reveals significant net selling over the past 12 months, with insiders selling $59.7 million worth of shares against $1.2 million purchased, while four premium gurus currently hold HIMS, with three adding and two trimming positions recently.
The recent 8% drop in HIMS shares is linked to Visa’s decision to place the company in its Acquirer Monitoring Program due to a surge in credit card dispute complaints related to its weight-loss subscription services. Visa plans to levy penalties close to $75,000, signaling regulatory and reputational risks for Hims & Hers. This development interrupts a strong rally that saw the stock gain over 20% in just five sessions, highlighting how operational issues can quickly impact investor sentiment in a highly speculative growth stock.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.